Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer
Numerous biologic approaches are being investigated as anti-cancer therapies in an attempt to induce tumor regression while circumventing the toxic side effects associated with standard chemo- or radiotherapies. Among these, tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) has shown p...
Main Authors: | Lyse A. Norian, Britnie R. James, Thomas S. Griffith |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/3/1/603/ |
Similar Items
-
Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
by: Oleg Mozhei, et al.
Published: (2020-12-01) -
Viral vectors for gene therapy : methods and protocols /
by: Machida, Curtis A.
Published: (2003) -
Appraisal for the Potential of Viral and Nonviral Vectors in Gene Therapy: A Review
by: Muhammad Hammad Butt, et al.
Published: (2022-07-01) -
Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
by: RACHANA eTRIVEDI, et al.
Published: (2015-04-01) -
How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?
by: Myriam Sainz-Ramos, et al.
Published: (2021-07-01)